Transurethral radiofrequency needle ablation of the prostate.
D001315:Australia; D054598:Blue Cross Blue Shield Insurance Plans; D002170:Canada; D017115:Catheter Ablation / Q000295:instrumentation / Q000379:methods*; D018795:Device Approval; D005060:Europe; D006801:Humans; D007557:Israel; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D011468:Prostatectomy / Q000295:instrumentation / Q000379:methods*; D011470:Prostatic Hyperplasia / Q000601:surgery*; D016032:Randomized Controlled Trials as Topic; D013019:South Africa; D013673:Technology Assessment, Biomedical; D014481:United States; D014486:United States Food and Drug Administration